Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hodgkin Disease 2Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Magnetic Resonance Spectroscopy 4Specimen Handling 3Cyclophosphamide 3Biopsy 3sodium-iodide symporter 2fludarabine 2cemiplimab 2alectinib 2X-Rays 2Stem Cell Transplantation 2Photons 2Nivolumab 2Immunoglobulin G 2Disulfides 2treosulfan 1sargramostim 1ruxolitinib 1repotrectinib 1duvelisib 1brigatinib 1belinostat 1Whole-Body Irradiation 1Vinblastine 1Suspensions 1Standard of Care 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Mycophenolic Acid 1Leukapheresis 1Hematopoietic Stem Cell Mobilization 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, Large-Cell, Anaplastic × Hematopoietic Stem Cell Mobilization × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡